Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-28

FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, Inc., expanding/adjusting its labeling and indications thro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENPEP (pancrelipase)

Snippet

SUPPL AP for ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE)